Of note, however, MEM-E/02 stained terminal stages of adenocarcinoma and lymph node metastatic lesions intensely, either owing to increased expression of β2m-free HLA-E with tumor progression or owing to expression of other β2m-free HLA-Ia molecules. The gene discussed is HLA-E; the disease is neoplasm.